AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Nov 16 2021
News
Pfizer Announces Deal To Provide COVID Pill To Low-Income Countries
In an agreement announced on Tuesday, Pfizer will permit its COVID-19 pill treatment to be manufactured and sold in countries that might not be able to otherwise afford the treatment.
The deal includes Pfizer working with Medicines Patent Pool (MPP), “a United Nations-backed public health organization working to increase access to life-saving medicines for low- and middle-income
The Daily Wire
Nov 04 2021
News
UK Becomes First to Approve Antiviral Home Pill for COVID-19
Britain has become the first country to approve an antiviral COVID-19 treatment that can be taken as a pill at home.
The UK national medicines regulator, the MHRA, announced on Nov. 4 that the antiviral Lagevrio (molnupiravir) had been authorised to treat mild to moderate COVID-19—in those with other risk factors, such as obesity, diabetes, or those over 60 years old.
“Today is a
The Epoch Times
Jun 18 2021
Headline Roundup
US to Spend $3.2B on Developing Antiviral COVID-19 Pills
The Department of Health and Human Services (HHS) announced Thursday that the U.S. will spend $3.2 billion on developing antiviral pills to treat COVID-19. The program, titled The Antiviral Program for Pandemics, will enhance current clinical trials of several potential COVID-19 treatments, with the goal of gaining FDA approval for at least one in the next year. Funding will come from
New York Times (News)
Axios 
New York Post (News)
Oct 11 2021
News
Merck asks FDA for emergency approval of its antiviral COVID-19 pill
Pharmaceutical giant Merck and its partner Ridgeback Biotherapeutics announced Monday that it has asked the Food and Drug Administration for emergency approval of its COVID-19 pill after the experimental drug showed “compelling results” in clinical trials.
The pill, called molnupiravir, cut the risk of hospitalization or death in patients with mild to moderate COVID-19 by about 50
New York Post (News)
Oct 01 2021
Headline Roundup
Merck Says It Has First Effective Antiviral Pill To Treat COVID-19
American drugmaker Merck announced Friday that it will seek emergency authorization of an experimental antiviral pill known as molnupiravir after it significantly reduced the worst effects of COVID-19 in clinical trials. The company said that in the trials, the treatment cut the risk of hospitalization or death in half when given to high-risk patients within the first five days of COVID-19
Politico
Washington Times
Associated Press
Jun 18 2021
News
US will spend $3B to develop antiviral pills for COVID-19
The US will invest more than $3 billion to advance the development of antiviral pills for COVID-19 and other pathogens to prepare for future pandemics, Dr. Anthony Fauci said Thursday.
The nation’s top infectious disease expert announced the $3.2 billion investment as part of a new “antiviral program for pandemics” to develop drugs to address symptoms caused by potentially dangerous
New York Post (News)
Jun 18 2021
News
HHS to invest $3 billion for antiviral pills against COVID-19
The Biden administration will invest $3.2 billion to foster the development of antiviral pills to help fight against COVID-19, the Health and Human Services department announced Thursday, with hopes the medication becomes available to the public as soon as the end of this year.
The big picture: Researchers had tested existing antivirals like remdesivir in hospitals on patients with
Axios
Oct 11 2021
Headline Roundup
Merck Asks FDA for Emergency Approval of Antiviral COVID-19 Pill
Pharmaceutical drugmaker Merck and its partner Ridgeback Biotherapeutics announced Monday that it has asked the Food and Drug Administration (FDA) for emergency approval of its COVID-19 pill. The company says the pill, called molnupiravir, reduced the risk of hospitalization or death in patients with mild to moderate COVID-19 by about 50% in a late-stage clinical trial. Researchers at Emory
STAT
New York Post (News)
USA TODAY
Jul 01 2022
Analysis
Under Obamacare, birth control pills are free. Why aren’t vasectomies?
In early May, after the Supreme Court draft opinion to overturn Roe v. Wade leaked, Google searches for vasectomies spiked — and then spiked again in late June when the final decision was handed down on June 24.
Bobby Najari, a urologist and assistant professor at NYU Langone Health, says some of that spike translated into a modest uptick in vasectomy consultations. “It came up in a
Vox
Nov 16 2021
Headline Roundup
Pfizer to Allow Generic Drugmakers to Manufacture COVID-19 Antiviral Pill
Pharmaceutical company Pfizer announced Tuesday that it would allow generic drug companies around the world to produce its COVID-19 antiviral pill by granting a royalty-free license to Medicines Patent Pool, a U.N.-backed nonprofit.
Merck made a similar arrangement for its COVID-19 pill last month. Pfizer also formally asked the FDA to grant emergency use authorization for its pill.
The Daily Wire
Associated Press
New York Times (News)